Federal Register / Vol. 71, No.
101 / Thursday, May 25, 2006 / Notices
$7.50 (25 cents per page reproduction
cost) payable to the U.S. Treasury.
Thomas A. Mariani, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 06–4833 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 2, 2006,
Applied Science Labs., Division of
Alltech Associates Inc., 2701 Carolean
Industrial Drive, State College,
Pennsylvania 16801, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of
Tetrahydrocannabinols (7370), a basic
class of controlled substance listed in
Schedules I.
The company plans to manufacture
metabolites of Delta–9–THC to be used
as chromatographic standards. These
compounds fall under drug code 7370
(Tetrahydrocannabinols)
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 24, 2006.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
cchase on PROD1PC60 with NOTICES
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7986 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005 16:42 May 24, 2006 Jkt 208001
30165
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated January 11, 2006, and
published in the Federal Register on
January 23, 2006, (71 FR 3545), Clariant
LSM (Missouri), Inc., 2460 W. Bennett
Street (or P.O. Box 1246, Zip: 65801),
Springfield, Missouri 65807–1229, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Phenylacetone (8501), and Methadone
Intermediate (9254), basic classes of
controlled substances listed in
Schedules II:
The company plans to manufacture in
bulk, for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Clariant LSM (Missouri) to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Clariant LSM (Missouri) to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7980 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated January 11, 2006 and
published in the Federal Register on
January 23, 2006, (71 FR 3545), Clinical
Trial Services (US), 2661 Audubon
Road, Audubon, Pennsylvania 19403,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Fentanyl (9801) and Oxycodone (9143),
PO 00000 Frm 00053 Fmt 4703 Sfmt 4703
basic classes of controlled substances
listed in Schedule II.
The company plans to import small
quantities of the listed controlled
substances in dosage form to conduct
clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. Sections 823(a) and
952(a) and determined that the
registration of Clinical Trial Services
(US) to import the basic class of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Clinical Trial Services
(US) to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
Sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
class of controlled substances listed.
Dated: May 18, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7981 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated February 16, 2006
and published in the Federal Register
on February 24, 2006, (71 FR 9606), JFC
Technologies, LLC., 100 West Main
Street, P.O. Box 669, Bound Brook, New
Jersey 08805, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Meperidine intermediate-
B (9233), a basic class of controlled
substance listed in Schedule II.
The company plans to import the
basic class of controlled substance for
the production of controlled substances
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
JFC Technologies, LLC to import the
basic class of controlled substances is
E:\FR\FM\25MYN1.SGM 25MYN1
 30166 Federal Register / Vol. 71, No. 101 / Thursday, May 25, 2006 / Notices
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated JFC
Technologies, LLC to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substances
listed.
Dated: May 17, 2006.
Joseph T. Ranazzissi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7976 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on February 22, 2006,
Lilly Del Caribe, Inc., Chemical Plant,
Kilometer 146.7, State Road 2,
Mayaguez, Puerto Rico 00680, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Dextropropoxyphen (9273), a basic class
of controlled substance listed in
Schedule II.
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
cchase on PROD1PC60 with NOTICES
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal RegisterRepresentative/ODL,
VerDate Aug<31>2005 16:42 May 24, 2006 Jkt 208001
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 24, 2006.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7977 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
December 9, 2005, Mallinckrodt Inc.,
3600 North Second Street, St. Louis,
Missouri 63147, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in Schedule
II:
Drug
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw (9650) .....................
Poppy Straw Concentrate (9670)
The company plans to import the
listed controlled substances for the
manufacture of controlled substances in
bulk for distribution to its customers.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
PO 00000 Frm 00054 Fmt 4703 Sfmt 4703
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than June 26, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7978 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
Schedule
By Notice dated December 8, 2005,
II
II
and published in the Federal Register
II on December 19, 2005, (70 FR 242),
II Norac, Inc., 405 S. Motor Avenue, P.O.
II Box 577, Azusa, California 91702, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
THC Tetrahydrocannabinols (7370), a
basic class of controlled substance listed
in Schedules I.
The company plans to manufacture
the listed controlled substance in bulk
for formulation into the pharmaceutical
controlled substance Marinol.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Norac, Inc. to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Norac,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
E:\FR\FM\25MYN1.SGM 25MYN1